296 filings
Page 5 of 15
8-K
uttd 1qi24m
27 Oct 16
Sarepta Therapeutics Announces Third Quarter 2016 Financial Results and Recent Corporate Developments
12:00am
8-K
z4cyjd
4 Oct 16
Entry into a Material Definitive Agreement
12:00am
8-K
0ss o9rfbeh
30 Sep 16
Other Events
12:00am
8-K
f8wk688qaccff3s0owea
23 Sep 16
Sarepta Therapeutics Announces Proposed Public Offering of Common Stock
12:00am
8-K
y7tevwndyfj
21 Sep 16
Departure of Directors or Certain Officers
12:00am
8-K
m8quipvwr5j3pbt1
20 Sep 16
Other Events
12:00am
8-K
9zf30bvk
19 Sep 16
Other Events
12:00am
8-K
3xaogg
19 Jul 16
Sarepta Therapeutics Announces Second Quarter 2016 Financial Results and Recent Corporate Developments
12:00am
8-K
7jhgotpl7 78
1 Jul 16
Departure of Directors or Certain Officers
12:00am
8-K
rpj54ctnwfin jg
28 Jun 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
cs3y unu6b4li9nb4oqe
10 Jun 16
Sarepta Therapeutics Announces Proposed Offering
12:00am
8-K
ocnjwrtfyoze528fawhm
7 Jun 16
Sarepta Therapeutics Announces FDA Request For Dystrophin Data Prior To Making A Decision on Eteplirsen NDA
12:00am
8-K
8rw ueg9339m
5 May 16
Sarepta Therapeutics Announces First Quarter 2016 Financial Results and Recent Corporate Developments
12:00am
8-K
6zmb1m jv5vuorx1eb
8 Mar 16
Sarepta Therapeutics Announces Long Term Plan to Consolidate Facilities within Massachusetts
12:00am
8-K
t4rt2nyy
25 Feb 16
Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2015 Financial Results and Recent Corporate Developments
12:00am
8-K
2erv7aq
15 Jan 16
Regulation FD Disclosure
12:00am
8-K
m6gsi1du5fbalhpx
5 Nov 15
Sarepta Therapeutics Announces Third Quarter 2015 Financial Results and Recent Corporate Developments
12:00am
8-K
j2oenlpfu29uj57
6 Oct 15
Sarepta Therapeutics Announces Proposed Public Offering of Common Stock
12:00am
8-K
j2b9a7v8z mrnhk
1 Oct 15
Sarepta Therapeutics Investor Update
12:00am
8-K
bw38g
1 Oct 15
Departure of Directors or Certain Officers
12:00am